What Is Ghrelin? The Hunger Peptide, Explained

What is ghrelin? Ghrelin is a 28-amino-acid hunger hormone peptide made mainly in the stomach. Its active form stimulates appetite and growth hormone release through GHS-R1a, the ghrelin receptor. That same switch is targeted by GHRP-2, GHRP-6, ipamorelin, hexarelin, and MK-677, which explains their overlapping effects.

What is ghrelin and what does it do?

Ghrelin is the body’s own signal for hunger and growth hormone (GH) release, not merely a stomach-rumbling alarm. Stomach cells supply most circulating ghrelin. The active peptide reaches the brain and pituitary, where it helps initiate eating and prompts a GH pulse. The “hunger hormone” nickname is fair, but incomplete.

The original discovery paper identified ghrelin as a 28-amino-acid stomach peptide that activates the growth hormone secretagogue receptor. Appetite was then tested directly in people. In a randomized, double-blind crossover study of nine healthy volunteers, intravenous ghrelin increased buffet energy intake by an average of 28% versus saline, and every participant ate more during the ghrelin visit. That is human controlled evidence, not an inference from mice.

The ghrelin hormone also sits inside a wider system involving meal timing, glucose control, gastrointestinal movement, reward, and energy balance. Those effects vary by tissue and study design. Calling ghrelin the hunger hormone gets the reader through the front door; it does not show the rest of the house.

Why must ghrelin carry a fat tag?

Ghrelin must be octanoylated at serine-3 before it can activate GHS-R1a. “Octanoylated” means an eight-carbon fatty-acid tag is attached to the third amino acid. The enzyme ghrelin O-acyltransferase (GOAT) installs that tag while the hormone is being processed. Without it, des-acyl ghrelin does not trigger the classical ghrelin receptor in the same way.

This is the chemistry detail most general health pages skip. A 2021 Open Biology review reports that ghrelin is the only protein known or predicted in the human proteome to carry a covalently attached octanoate and the sole known GOAT substrate. One tiny lipid tail decides whether the key fits the receptor. Human biology does occasionally indulge in custom hardware.

The distinction also matters when reading blood tests or studies. “Total ghrelin” can combine acylated and des-acyl forms, even though the forms are not interchangeable at GHS-R1a. A paper measuring total concentration has not automatically measured receptor-active ghrelin.

What is the ghrelin receptor GHS-R1a?

The ghrelin receptor GHS-R1a is a G-protein-coupled receptor found prominently in the pituitary and hypothalamus. Ghrelin is its natural agonist, meaning ghrelin switches the receptor on. Pituitary activation helps release GH; hypothalamic signaling connects the same receptor family to appetite and energy balance.

GHS-R1a was known before ghrelin was discovered. Researchers had already made synthetic growth hormone secretagogues that activated an “orphan” receptor with no identified natural ligand. Ghrelin turned out to be the missing native key. That history explains the backwards-sounding vocabulary: several synthetic ghrelin mimetics predate the hormone they mimic.

GHS-R1a also has unusually high constitutive activity, meaning the receptor can signal somewhat even when no ligand is bound. That basal activity is mechanistic evidence, not proof that changing the receptor will improve muscle, fat loss, recovery, or longevity in people.

Which GH peptides act like ghrelin?

GHRP-2, GHRP-6, ipamorelin, and hexarelin are peptide agonists of GHS-R1a; MK-677 reaches the same receptor but is a non-peptide small molecule. These belong to the ghrelin-receptor lane of GH secretagogues. Sermorelin, tesamorelin, and CJC-1295 instead act through the GHRH receptor, a separate lane covered in GHRH vs GHRP.

Compound	What it is	Appetite evidence
GHRP-2	Peptide GHS-R1a agonist	Human controlled evidence: GHRP-2 increased food intake in healthy men
GHRP-6	Peptide GHS-R1a agonist	Appetite stimulation fits the receptor and preclinical record; precise human outcome evidence is thinner
Ipamorelin	Selective peptide GHS-R1a agonist	Human studies establish a GH pulse; they do not establish a predictable hunger increase
Hexarelin	Peptide GHS-R1a agonist	Human GH-release evidence exists; appetite is not a well-established human endpoint
MK-677	Oral non-peptide GHS-R1a agonist	Increased appetite appears in randomized human trials

The shared receptor explains family resemblance, not identical effects. Dose, exposure time, receptor signaling bias, and activity at other targets can change the result. “Ghrelin agonist” is a mechanism label, not a promise that every compound produces the same hunger or GH curve.

Does MK-677 raise ghrelin?

MK-677 does not need to raise ghrelin concentration because it mimics ghrelin at the receptor. The cleaner answer to “does MK-677 raise ghrelin” is that MK-677, or ibutamoren, directly activates GHS-R1a. The receptor receives a ghrelin-like message even if the body’s measured ghrelin level does not increase.

In a two-year randomized trial involving 65 adults aged 60 to 81, MK-677 increased GH and insulin-like growth factor 1. Increased appetite was the most frequent side effect and generally subsided within a few months. The same trial found higher fasting glucose, reduced insulin sensitivity, mild edema, and muscle pain, so ravenousness was not the only signal the receptor program touched.

Regulatory reality is separate from mechanism. As of 2026, the FDA says ibutamoren is not approved. The 2026 World Anti-Doping Agency list prohibits ghrelin mimetics and GH-releasing peptides at all times, explicitly naming ibutamoren, ipamorelin, ghrelin, hexarelin, GHRP-2, and GHRP-6.

Is ghrelin simply bad for fat loss?

Ghrelin is not a toxin to eliminate; ghrelin is a normal signal that coordinates appetite with energy availability and GH release. Dieting can raise hunger signals, but a ghrelin measurement alone does not dictate body-fat change. Food environment, energy intake, sleep, other hormones, and behavior still matter.

The evidence tiers keep the story straight. Ghrelin increasing short-term food intake has human controlled evidence. MK-677 increasing appetite has randomized human evidence. Ipamorelin causing a specific degree of hunger does not. Claims that a supplement can “shut off” ghrelin or that every GHS-R1a agonist makes everyone ravenous run ahead of the data.

What is ghrelin, then, for someone comparing GH compounds? Ghrelin is the concept parent: the natural ligand that makes GHRPs and MK-677 understandable as one receptor family. Start with the receptor, separate GH measurements from physique outcomes, and grade appetite evidence compound by compound. The growth-hormone peptide hub keeps those records in their proper lanes.